🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jonathan Kimmelman

McGill University

ORCID: 0000-0003-1614-6779
MedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update”.

ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update

Stem Cell Reports(2021)10.1016/j.stemcr.2021.05.012
N/A
0.887DataRank · unranked
368 citations

Eric Anthony, Roger A. Barker, Tania Bubela, Ali H. Brivanlou, Melissa Carpenter +42 more

Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad013
N/A
0.496DataRank · unranked
12 citations

Kara W Chew, Carlee Moser, David A. Wohl, Eric S. Daar, Jonathan Z. Li +42 more

Practical steps to identifying the research risk of pragmatic trials

Clinical Trials(2022)10.1177/17407745211063476
N/A
0.434DataRank · unranked
17 citations

Jonathan Kimmelman, Scott Y. H. Kim

Preclinical assessment for translation to humans: The PATH approach for assessing supporting evidence for early-phase trials and innovative care

Med(2024)10.1016/j.medj.2024.07.014
N/A
0.396DataRank · unranked
13 citations

Patrick Bodilly Kane, Selin Bicer, Benjamin Gregory Carlisle, Jonathan Kimmelman

There is no upper limit on the maximum effect that can be detected in randomized trials

Journal of Clinical Epidemiology(2025)10.1016/j.jclinepi.2025.111828
N/A
0.223DataRank · unranked
3 citations

Iztok Hozo, Renata Iskander, Austin J. Parish, Jonathan Kimmelman, Benjamin Djulbegović +1 more

Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy

Clinical Infectious Diseases(2024)10.1093/cid/ciae441
N/A
0.165DataRank · unranked
2 citations

Sean S. Brummel, Muktar H. Aliyu, Lynda Stranix‐Chibanda, George Uchenna Eleje, Ifeanyichukwu U. Ezebialu +56 more

Why IRBs should protect bystanders in human research

Bioethics(2020)10.1111/bioe.12812
N/A
0DataRank · unranked
9 citations

Jonathan Kimmelman

Progress in Cancer Therapeutics: Is There an Upper Limit on the Maximum Effect that Can Be Detected in Randomized Trials

SSRN Electronic Journal(2025)10.2139/ssrn.5159364
N/A
0DataRank · unranked
0 citations

Iztok Hozo, Renata Iskander, Austin J. Parish, Jonathan Kimmelman, John P. A. Ioannidis +2 more

Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum

Clinical Infectious Diseases(2024)10.1093/cid/ciae001
N/A
0DataRank · unranked
12 citations

Sean S. Brummel, Lauren Ziemba, Lameck Chinula, Katie McCarthy, Lee Fairlie +88 more

Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development

Neurology(2024)10.1212/wnl.0000000000209533
N/A
0DataRank · unranked
0 citations

Robyn Mellett, Karine Vigneault, Maya McKeown, Jason Karlawish, Erika F. Augustine +3 more